Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals. The company was founded in 1917 and is based in Buenos Aires, Argentina.
Frequently asked questions
What sector does Instituto Rosenbusch S.A. (ROSE) operate in?
Instituto Rosenbusch S.A. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Instituto Rosenbusch S.A. (ROSE) current stock price?
As of the latest data, Instituto Rosenbusch S.A. stock price is ARS 161.00, with a previous close of ARS 157.50. Instituto Rosenbusch S.A. gained ARS 3.50 in the last trading session, representing a 2.22% increase.
What is Instituto Rosenbusch S.A. (ROSE) current market capitalization?
Instituto Rosenbusch S.A. market cap is approximately 6.86 billion.
What is Instituto Rosenbusch S.A. (ROSE) Earnings Per Share (EPS)?
The trailing EPS is -ARS 104.96.
Does Instituto Rosenbusch S.A. (ROSE) pay dividends?
No. Instituto Rosenbusch S.A. does not pay a dividend.
What is Instituto Rosenbusch S.A. (ROSE) beta (volatility) score?
Instituto Rosenbusch S.A. has a beta of 0.014, indicating lower volatility than the overall market.
